Charles River Laboratories | CRL - Loan Capital

Stock Price
189.24
Daily Change
5.54 3.02%
Monthly
-12.70%
Yearly
15.54%
Q1 Forecast
204.00

Charles River Laboratories reported $2.19B in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Agilent USD 3.05B 300M Sep/2025
Align Technology USD 0 0 Dec/2024
Bio-Rad Laboratories USD 1.2B 300K Sep/2025
Bruker USD 1.98B 395.4M Sep/2025
Cardinal Health USD 8.35B 633M Dec/2025
Charles River Laboratories USD 2.19B 146.92M Sep/2025
Cigna USD 30.95B 4.47B Sep/2025
CVS Health USD 60.51B 3.22B Sep/2025
Danaher USD 18.42B 1.58B Dec/2025
Dentsply International USD 2.02B 201M Sep/2025
Elevance Health USD 30.8B 376M Dec/2025
Galapagos EUR 5.76M 290K Sep/2025
Hologic USD 2.5B 2.1M Dec/2025
Humana USD 12.61B 21M Sep/2025
Illumina USD 1.49B 496M Dec/2025
Incyte USD 35.37M 3.61M Sep/2025
IQVIA Holdings USD 13.88B 1.09B Dec/2025
Laboratory Of America USD 5.15B 3.9M Sep/2025
Lonza CHF 4.24B 602M Dec/2024
McKesson USD 5.43B 586M Dec/2025
Merck EUR 10.45B 4.15B Sep/2025
Mettler Toledo International USD 2.09B 58.01M Dec/2025
Novartis USD 24.24B 174M Sep/2025
Pfizer USD 57.41B 93M Sep/2025
Quest Diagnostics USD 5.17B 2M Sep/2025
Revvity USD 2.63B 583.63M Sep/2025
Thermo Fisher Scientific USD 35.85B 4B Dec/2025
United Therapeutics USD 100M 100M Jun/2024
UnitedHealth USD 72.32B 79M Dec/2025
Waters USD 947.21M 249.76M Sep/2025
West Pharmaceutical Services USD 202.7M 100K Sep/2025